SARS – CoV – 2 Spike RBM (receptor binding motif), 438 – 458 – 0.5 mg

Overview

The SARS-CoV-2 Spike RBM (receptor binding motif) peptide, specifically the sequence from residues 438 to 458, is an essential component for researchers studying COVID-19. This peptide is derived from the receptor binding domain (RBD) of the spike protein, providing critical insights into viral receptor interactions and potential therapeutic targets. By incorporating this peptide into your research, you can facilitate a deeper understanding of the mechanisms of viral entry and immune response.

Key Features

• Sequence: RBM peptide sequence from residues 438-458.
• High purity and quality, suitable for various applications.
• Key component for studies on SARS-CoV-2 spike protein interactions.
• Ideal for use in assays and diagnostic applications.
• Available in a 0.5 mg quantity, ensuring adequate supply for experimental needs.

Specifications

FAQ

What are the applications of this peptide?

This peptide is primarily used in research studying SARS-CoV-2 interactions with host cells. It can be utilized in various assays, including binding assays and immunological studies.

How should I store the SARS-CoV-2 Spike RBM peptide?

For optimal stability, store the peptide at -20°C in a dry environment. Avoid repeated freeze-thaw cycles to maintain its integrity.

Can this peptide be used in vivo studies?

This peptide is designed for in vitro applications. For in vivo studies, consult with our team to explore suitable alternatives that match your research objectives.

Enhance your research on SARS-CoV-2 with our quality peptide offerings. Explore our full range of peptides or consider complementary products like Autocamtide-2 and PKG Substrate for more comprehensive study results.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled